Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report

BACKGROUND: The ProteomeLab™ PF 2D platform is a relatively new approach to global protein profiling. Herein, it was used for investigation of plasma proteome changes in amyotrophic lateral sclerosis (ALS) patients before and during immunization with glatiramer acetate (GA) in a clinical trial. RESU...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlautman, Joshua D, Rozek, Wojciech, Stetler, Robert, Mosley, R Lee, Gendelman, Howard E, Ciborowski, Pawel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543004/
https://www.ncbi.nlm.nih.gov/pubmed/18789151
http://dx.doi.org/10.1186/1477-5956-6-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543004/
https://www.ncbi.nlm.nih.gov/pubmed/18789151
http://dx.doi.org/10.1186/1477-5956-6-26

Ejemplares similares